ESAB ESAB Corp
General Industrial Machinery & Equipment, NEC · NYSE · SEC CIK 1877322 · Fiscal year ends 12/31
Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.0%
TTM net income YoY-35.5%
TTM EPS YoY-37.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin37.6%
Operating margin11.2%
Net margin5.1%
FCF margin5.8%
EBITDA margin15.0%
Returns
ROE6.7%
ROA2.8%
ROIC (approx.)6.9%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets59.9%
Debt / equity0.91x
Current ratio1.92x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.60x
Accruals ratio-1.6%
Payout ratio16.5%
Capex / revenue2.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.84B | $2.74B |
| Cost of revenue | $1.79B | $1.70B |
| Gross profit | $1.05B | $1.04B |
| R&D expense | $44.00M | $39.20M |
| SG&A expense | $608.42M | $579.78M |
| Operating income | $412.17M | $447.45M |
| Pretax income | $328.26M | $370.40M |
| Income tax | $69.16M | $77.35M |
| Net income | $226.77M | $264.84M |
| EBITDA | $496.27M | $514.24M |
| EPS (basic) | 3.71 | 4.36 |
| EPS (diluted) | 3.67 | 4.31 |
| Dividends declared per share | 0.38 | 0.30 |
| Weighted avg. shares (diluted) | 61.27M | 61.10M |
| Balance sheet | ||
| Cash & equivalents | $185.86M | $249.36M |
| Receivables | $451.30M | $370.32M |
| Inventory | $481.76M | $403.71M |
| Current assets | $1.26B | $1.15B |
| PP&E, net | $381.88M | $298.35M |
| Goodwill | $1.95B | $1.65B |
| Intangibles | $673.01M | $487.99M |
| Total assets | $4.77B | $4.03B |
| Current liabilities | $664.79M | $632.05M |
| Short-term debt | $2.41M | $15.00M |
| Long-term debt | $1.23B | $1.06B |
| Total debt | $1.23B | $1.08B |
| Total liabilities | $2.55B | $2.23B |
| Shareholders' equity | $2.17B | $1.77B |
| Net debt | $1.05B | $826.38M |
| Shares outstanding | 60.72M | 60.52M |
| Cash flow statement | ||
| Operating cash flow | $260.57M | $355.40M |
| Capital expenditure | $47.29M | $51.78M |
| Free cash flow | $213.28M | $303.62M |
| Investing cash flow | -$479.88M | -$205.70M |
| Financing cash flow | $113.70M | $31.67M |
| Depreciation & amortization | $84.11M | $66.79M |
| Stock-based compensation | $16.94M | $19.78M |
| Dividends paid | $21.91M | $16.99M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.